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Abstract
Objective Although an extensive amount of research has
demonstrated the positive effects of an enamel matrix deriva-
tive (EMD) on soft tissue wound healing around intrabony
defects, little information is available describing its effect on
peri-implant soft tissues, an area that has recently gained tre-
mendous awareness due to the increasing prevalence of peri-
implantitis. The aim of the present study was to assess the role
of EMD when gingival fibroblasts were cultured on titanium
surface with different surface topographies.
Methods Human primary gingival fibroblasts were cultured
on pickled (PT) and sand-blasted with large grit followed by
acid etching (SLA) surfaces and assessed for cell adhesion at
2, 4, and 8 h, cell morphology at 2, 4, 8, and 24 h as well as
cell proliferation at 1, 3, and 5 days post-seeding. Further-
more, genes encoding collagen 1a1, vascular endothelial
growth factor-A (VEGF-A), and fibronectin were assessed
by real-time PCR. Human gingival fibroblasts were also quan-
tified for their ability to synthesize a collagen matrix on the
various titanium surfaces with and without EMD by immuno-
fluorescence staining.
Results The results from the present study demonstrate that
EMD significantly increased cell spreading at 2, 4, 8, and 24 h
on PT surfaces and 4, 8, and 24 h on SLA surfaces. Further-
more, proliferation at 5 days on PT surfaces and 3 and 5 days
on SLA surfaces was also increased for groups containing
EMD. Real-time PCR results demonstrated that the culture
of gingival fibroblasts with EMD significantly increased ex-
tracellular matrix synthesis of collagen 1 as well as improved
mRNA levels of VEGF-A and fibronectin. Collagen1
immuno-fluorescent staining revealed a significantly higher
area of staining for cells seeded on PT + EMD at 7 and 14
days and 14 days for SLA + EMD when compared to control
samples.
Conclusion The results from the present study favor the use of
EMD for colonization of gingival fibroblasts on titanium sur-
faces by increasing cell growth, spreading, and synthesis of an
extracellular matrix. The improvements were primarily irre-
spective of surface topography. Future animal and human
studies are necessary to fully characterize the beneficial effects
of incorporating EMD during soft tissue regeneration of im-
plant protocols.
Clinical relevance The use of EMDmay speed up the quality
of soft tissue integration around dental implants by facilitating
gingival cell attachment, proliferation, and matrix synthesis of
collagen 1.
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Introduction
Enamel matrix derivative (EMD) has been used for a variety
of clinical applications for the regeneration of lost periodontal
tissues including cementum, periodontal ligament, and
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alveolar bone [1]. The major components of EMD,
amelogenins, are a group of hydrophobic proteins that account
for approximately 95% of the total protein content [2]. These
proteins self-assemble into supramolecular aggregates that
form an insoluble extracellular matrix that have as function
to control the ultrastructural organization of developing enam-
el crystallites [2]. Other proteins that have been reported in the
enamel matrix include enamelin, ameloblastin (also called
amelin or sheathlin), amelotin, apin, and various proteinases
[3, 4].
The rationale for using EMD is the observation that
amelogenins, which until then were considered an enamel-
specific protein, were found deposited onto the surface of
developing tooth roots prior to cementum formation [5–10].
It was later observed that these proteins largely contribute to
the differentiation of periodontal tissues into new cementum
formation, and thereafter a series of studies has demonstrated
the role of EMD in osteoblast differentiation and periodontal
ligament formation [11–14]. The commercially available ex-
tract of EMD (Emdogain®, Straumann AG, Basel, Switzer-
land) has been demonstrated to successfully stimulate the re-
generation of periodontal tissues and increase clinical attach-
ment levels when employed on denuded root [11, 12, 15].
Recently, the effects of EMD on soft tissue wound healing
and inflammatory resolution were investigated in a review
article [16]. It was found that EMD has the ability to signifi-
cantly decrease interleukin-1b and RANKL expression, in-
crease prostaglandin E2 and OPG expression, increase prolif-
eration and migration of T lymphocytes, induce monocyte
differentiation, increase bacterial and tissue debris clearance,
as well as increase fibroplasias and angiogenesis by inducing
endothelial cell proliferation, migration, and capillary-like
sprout formation. The outcomes from this review article indi-
cate that EMD is able to affect substantially the inflammatory
and healing responses, and further clinical reports also point to
the fact that EMD is able to increase wound healing in peri-
odontal tissues [17–21]. This is further exemplified by the fact
that EMD is also successfully packaged and sold under the
trademark name Xelma® (Mölnlycke Health Care, Gothen-
burg, Sweden) for the treatment of hard-to-heal skin ulcers
such as venous leg ulcers, diabetic foot ulcers, and pressure
ulcers, by functioning as a temporary matrix that improves cell
adhesion and subsequent tissue/wound healing [22–30].
One area of research that has gained tremendous awareness
in recent years is that of peri-implantitis [31–37]. With a con-
tinuously rising number of patients now affected by peri-
implantitis, the need for a better understanding of the interac-
tions that take place during its progression becomes vital for
its future resolution. Since the majority of the initial research
in the field of implant dentistry focused on hard tissue
osseointegration of titanium implants [38–41], much less fo-
cus has addressed the soft tissues surrounding the implant
collar. The gingival/epithelial seal around the implant collar
is thought to prevent bacterial infiltration and, a better attach-
ment of gingival cells around the implant collar may inhibit
disease progression of peri-implantitis. Since EMD has been
shown to increase soft tissue wound healing, increase extra-
cellular matrix synthesis, and speed up inflammatory resolu-
tion, the aim of the present study was to investigate the rela-
tionship between gingival cells on titanium surfaces with and
without EMD. Therefore, human primary gingival fibroblasts
were cultured on pickled (PT) and sand-blasted with large grit
followed by acid etching (SLA) surfaces and assessed for cell
adhesion, cell morphology, as well as cell proliferation at var-
ious time intervals. Furthermore, genes encoding extracellular
matrix formation including collagen 1, vascular endothelial
growth factor-A (VEGF-A), and fibronectin were assessed
by real-ime PCR. Collagen 1 staining following 1 and 2 weeks
of cell culture was assessed by immunofluorescence to assess
the quantity and morphology of the extracellular matrix on the
various implant surfaces with and without EMD.
Materials and methods
Preparation of PT and SLA titanium discs
Grade 2 unalloyed Ti sheets were punched into 5-mm-
diameter samples. Smooth pickled Ti (PT) surfaces were pre-
pared using dilute nitric acid to clean the surfaces, followed by
washing in reverse-osmosis-purified water. Roughened SLA
topography surfaces were prepared by blasting the Ti with
corundum particles, followed by etching with HCl/H2SO4.
The surface topographies of PT and SLA surfaces can be
visualized in Fig. 1.
EMD preparation
EMD was prepared according to Institut Straumann AG stan-
dard as previously described [42–44]. Briefly, 0.7 ml (one
vial) of 30 mg/ml EMD was dissolved in 1.4 ml of 4C sterile
0.1% acetic acid to make a stock solution of 10mg/ml. During
experimental seeding, stock EMD was diluted with 1:100 in
α-MEM (Hyclone, Thermo Fisher Scientific Inc, Waltham,
MA, USA) containing 10% fetal bovine serum (FBS,
Hyclone, Thermo Fisher Scientific Inc). Samples containing
EMDwere then seeded in plates together with human gingival
fibroblasts, while control samples without EMD were seeded
containing medium alone which contains 10% FBS.
Isolation of human gingival fibroblasts
Gingival tissues were harvested from healthy donors under-
going third molar extraction. Ethical approval and consent
was obtained from all volunteers. Collected tissues were
washed three times with phosphate-buffered saline (PBS;
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150 mM NaCl, 20 mM sodium phosphate, pH 7.2) supple-
mented with antibiotics (100 U/ml penicillin,100mg/ml strep-
tomycin) and cut into small pieces with sterilized surgical
scissors.
The gingival tissue pieces were then transferred into T25
tissue culture flasks containing minimal α-MEM and were
allowed to adhere for 2 h. Then, 3 ml of α-MEM containing
20% fetal bovine serum and antibiotics (100 U/ml medium of
penicillin, 100 mg/ml streptomycin, HyClone, Thermo Fisher
Scientific Inc) was added. Cultures were maintained in an
incubator at 37°C in an air atmosphere with 95% humidity
and 5% CO2. After 1 week, when cells reached confluency,
cells were trypsinized, and cultures were expanded inα-MEM
containing 10% fetal bovine serum. Human gingival fibro-
blasts used for experimental analysis were chosen from pas-
sages 2–4.
Cell adhesion and proliferation assays
Cells were seeded onto titanium discs in 24-well plates at a
density of 1.5×104 cells per Ti structure and cultured for 2, 4,
and 8 h for the adhesion assay. Cell number was measured by
staining cells with 4′,6-diamidino-2-phenylindole (DAPI) as
previously described [45]. At each time point, the Ti structures
were washed with PBS to remove non-attached cells and fixed
in 4% formaldehyde for 10 min, followed by staining with
DAPI. Images were captured on an Olympus DP71 fluores-
cence microscope (Olympus Co, Japan). Ten fields of view
were captured per sample, and nuclei were counted using
Image J software as previously described. For the cell prolif-
eration assays, HGFs were seeded on titanium discs in 96-well
plates at a density of 2000 cells per well with culture medium
with versus without EMD. At time points 1, 3, and 5 days, cell
number of HGFs was determined by the Cell Counting Kit-8
(Dojindo, Japan) and measured by a microplate reader scan-
ning at 450 nm (PowerWave XS2, BioTek, Winooski, VT,
USA) as previously described [46]. Samples were performed
in triplicate with three independent experiments performed.
Cell morphology
Human gingival fibroblasts were plated at a density of 10,000
cells on PTand SLA surfaces either with versus without EMD
in a 24-well plate. At 2, 4, 8, and 24 h, cells were fixed using
4% formaldehyde followed by rinsing with PBS for 5 min.
Then, cells were stained with 5 ug/ml phalloidin-FITC (Sig-
ma–Aldrich) for 1 h in dark conditions at 37°C as previously
described [44]. Finally, a drop of DAPI was added for 3 min to
visualize the cell nuclei. Images were captured from each sur-
face on anOlympus DP71 fluorescencemicroscope (Olympus
Co, Japan) for samples with and without EMD and compared
for morphological differences. The planar area of the cells was
measured using Image J software. A minimum of 50 cells
from each treatment group was counted and analyzed for sta-
tistical variance between samples as previously described
[44].
ECM-related gene expression
For real-time PCR experiments, 10,000 cells were seeded onto
PT and SLA surfaces with and without EMD. After 5 days of
culture, total RNA was isolated from HGF cells using
Fig. 1 Scanning electron
microscopy of PT and SLA
surfaces at ×40 (a and b) and
×6000 (c and d) magnification
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AxyPrepTM Multisource Total RNA Miniprep Kit
(AXYGEN, Union City, CA, USA) according to the manu-
facturer’s protocol. The RNA concentration was determined
by a NanoDrop 2000 UV–vis spectrophotometer as previous-
ly described [47]. A total of 1 ug RNA solution was immedi-
ately reverse-transcribed to cDNA using a Transcriptor First
Strand cDNA Synthesis Kit (Roche, Basel, Switzerland), and
the final volume is 100 ul. The sequences of primers for col-
lagen type I alpha1 (COL1A1), VEGF-A, fibronectin (FN1),
and GAPDH genes of human are listed in Table 1. Real-time
RT-PCR was performed using 25 ul final reaction volume of
QuantiFastTM SYBR Green PCR Kit (QIAGEN, Venlo, Hol-
land). Twomicroliters of total RNAwas used per sample well.
Quantitative real-time RT-PCR was performed with a CFX
Connect™ Real-Time PCR Detection System. The delta-
delta Ct method was used to calculate gene expression levels
relative to house-keeping gene GAPDH and normalized to
control cells (blank well without Ti structure). Each sample
contained pooled mRNA collected from ten Ti surfaces, and
all samples were log-transformed. All samples were per-
formed in triplicate with three independent experiments
performed.
Collagen type I staining
HGFs were plated at a density of 5000 cells per structure in a
24-well plate. The culture medium was changed every 3 days.
At 1 and 2 weeks, Ti structures were washed with PBS and
fixed with 4% formaldehyde for 10 min at room temperature
(RT). Cells were then permeabilized with 0.5% Triton X-100
(Merck, Germany) in PBS for 3 min at room temperature.
Subsequently, cells were washed and incubated for 1 h at
37°C with polyclonal rabbit to collagen type I (1:100) (Boster
Biological Technology Ltd, Wuhan, China) diluted 1:100 in
PBS containing 2% bovine serum albumin (BSA, Roche).
After washing with PBS, cells were incubated for 1 h at
37°C with FITC-conjugated-goat-anti-rabbit (Invitrogen)
(1:500) diluted in PBS containing 2% BSA. The cells were
washed again and incubated with DAPI for 3 min. Images
were captured from each surface on an Olympus DP71 fluo-
rescence microscope (Olympus Co, Japan). The optical den-
sity (OD) of the fluorescent collagen staining was quantified
from three independent experiments using Image J software.
Statistical analysis
Statistical analyses was analyzed by one-way ANOVA with
Bonferroni test, using Graphpad Software v. 4 (Graphpad
Software, La Jolla, CA, USA), and statistical significance




SEM images of PT and SLA surfaces demonstrated markedly
different surface topographies (Fig. 1). At a magnification of
×40, PT surfaces appear relatively smooth with only slightly
appearing valleys observed at ×6000 magnification (Fig. 1c).
In contrast, SLA surfaces appeared roughened at ×40 magni-
fication with many micro and nanotopographies visualized at
×6000 magnification (Fig. 1d).
Human gingival fibroblast attachment
HGFs attached similarly on both PTand SLA surfaces with no
significant difference being observed with or without EMD at
all time points (Fig. 2). At 2 h post-seeding, it was observed
that approximately 20–25 cells per field of viewwere attached
to all surfaces irrespective of EMD coating with no significant
difference observed between groups (Fig. 2). By 4 h, cell
numbers had increased to 40–45 cells per group irrespective
of surface topography or the presence of EMD (Fig. 2). This
was consistent at 8 h where no significant difference could be
observed between all treatment groups (Fig. 2). Analysis of
cell shape by immunofluorescence staining demonstrated that
cells seeded on PT surfaces alone attached at 2 h; however,
their appearance was still round with very little cell spreading
observed (Fig. 3). In contrast, when human gingival fibro-
blasts were seeded with EMD, cells began to spread on PT
surfaces (Fig. 3). A similar observation was observed through-
out the time course of these experiments with the highest cell
spreading visually observed for cells seeded on PT surfaces in
combination with EMD (Fig. 3). The average planar area of
cells seeded on the different surfaces with/without EMD was
then quantified for spreading area (Fig. 4). It was first ob-
served at 8 and 24 h that cells seeded on SLA alone had
significantly less spreading when compared to PT alone
(p<0.05; Fig. 4). Interestingly, PT samples cultured with
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EMD demonstrated significantly higher cell spreading when
compared to PT alone samples at all time points, and cells
seeded on SLA surfaces with EMD additionally demonstrated
significantly higher values at 4, 8, and 24 h when compared to
SLA alone (Fig. 4).
Human gingival fibroblast proliferation
The analysis of cell proliferation demonstrated significant
changes in cell number that were influenced by both surface
topography as well as EMD (Fig. 5). At 1 day post-seeding, an
equal number of cells was observed on all surfaces with an
equal number of cells irrespective of EMD or surface
topography (Fig. 5). By 3 days, however, it was observed that
cells seeded on SLA demonstrated significantly lower cell
numbers when compared to PT surfaces (Fig. 5). When
EMD was added to culture media, HGFs seeded on SLA
surfaces demonstrated significantly higher cell numbers than
HGFs seeded on control SLA surfaces without EMD at 3 days
(Fig. 5). No significant difference was observed between PT+
EMD and control PT surfaces at 3 days post-seeding (Fig. 5).
By 5 days, it was again observed that the control SLA surfaces
demonstrated significantly lower cell numbers when com-
pared to PT surfaces (Fig. 5). Furthermore, cells seeded with
EMD on both PT and SLA surfaces demonstrated significant-
ly higher cell numbers at 5 days when compared to their re-
spective controls (Fig. 5).
Human gingival fibroblast expression of FN1, VEGF-A,
and COL1A1
Gingival fibroblasts were investigated for mRNA levels for
genes encoding FN1, VEGF-A, and COL1A1 as assessed by
real-time PCR at 5 days post-seeding (Fig. 6). COL1A1 dem-
onstrated significantly higher levels of mRNA on both PTand
SLA surfaces when HGFs were seeded with EMD at 5 days
post-seeding (Fig. 6a). No differences could be observed be-
tween control PTand SLA surfaces. Analysis of mRNA levels
of cell adhesion molecule FN1 demonstrated that cells seeded
in the presence of EMD also demonstrated elevated levels of
FN1 when compared to their respective control surfaces
(Fig. 6b). It was also observed that FN1 expression was higher
on SLA surfaces when compared to PT surface irrespective of
EMD (Fig. 6b). This trend was also observed for the expres-
sion of VEGF-A (Fig. 6c). HGFs seeded with EMD
Fig. 2 Effects of surface topography and EMD on human gingival
fibroblast cell adhesion. Average cell number of cells seeded on PT
control, PT EMD, SLA control, and SLA+EMD at 2, 4, and 8 h post-
seeding. No significant differences were observed for human gingival
fibroblast attachment levels between EMD-treated surfaces versus
control surfaces at all time points. Data are means ± SE
Fig. 3 EMD promotes initial cell
spreading of human gingival
fibroblasts (HGFs) on both PT
and SLA titanium surfaces at time
points 2, 4, 8. and 24 h. Cells were
stained for F-actin (green) and
nuclei (blue). HGFs attached to
PT surfaces were well spread and
circular in shape by 2 h and
continued to spread throughout
the experiment. On SLA surfaces,
HGFs formed more elongated
shapes with microspikes observed
due to the confinements of the
roughened surface topography
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demonstrated significantly higher levels of VEGF-A when
compared to their respective controls (Fig. 6c). Furthermore,
cells seeded on control SLA surfaces also demonstrated sig-
nificantly higher levels when compared to control PT surfaces
(Fig. 6c).
Collagen type I staining
Analysis of collagen type 1 expression was investigated in
order to visualize and quantify the extracellular matrix depo-
sition of human gingival fibroblasts over time on both PT and
SLA surfaces (Fig. 7). It was observed that at 7 days post-
seeding, most of the collagen expression was localized intra-
cellularly with little deposition observed on PT and SLA sur-
faces without EMD (Fig. 7). In cell culture with EMD, immu-
nofluorescence of collagen 1 was gradually observed outside
the cells with an extracellular matrix deposited within the
cell’s periphery (Fig. 7). By 2 weeks, a continuous layer of
extracellular matrix was observed on both surfaces receiving
EMD (Fig. 7). It was observed also that a more uniform layer
of collagen 1 staining was observed on PT surfaces when
compared to SLA, which is likely due to surface topography
(Fig. 7). Interestingly, the control PT and SLA samples began
to secrete collagen outside the cell; however, non-uniformity
was observed with very little collagen synthesis observed be-
tween cells (Fig. 7). Quantification of staining area revealed a
significantly higher amount of staining area observed on PT
surfaces coated with EMDwhen compared to PTalone at both
7 and 14 days (Fig. 8). A statistically significant difference
was observed for SLA + EMD when compared to SLA alone
at 2 weeks only (Fig. 8). No significant difference could be
observed between control PT and control SLA surfaces at
either time point (Fig. 8).
Discussion
EMD is a widely used biologic agent capable of enhancing
periodontal wound healing/regeneration [1]. A systematic re-
view on the in vitro roles of EMD has been well documented
in both PDL cells, cementoblasts and osteoblasts [14]. EMD
has a significant influence on cell adhesion, cell proliferation,
and cell differentiation of many cell types by mediating cell
attachment, spreading, proliferation, and survival as well as
expression of transcription factors, growth factors, cytokines,
extracellular matrix constituents, inter-cellular communica-
tion molecules, and other molecules involved in the regulation
of bone remodeling [14, 45]. Furthermore, there have been
numerous reports that also indicate that EMD is able to sig-
nificantly upregulate osteoblast proliferation or differentiation
of hard tissues on titanium surfaces in vitro and increase the
speed and quality of new bone formation in vivo [44, 48–51].
Fig. 4 Average planar area of cells attached to PT and SLA surface with
and without EMD at 2, 4, 8 and 24 h post-seeding. EMD significantly
increased cell spreading on PT surfaces at all time points and on SLA
surfaces at 4, 8, and 24 h. It was also noted that surface cell spreading was
significantly greater on PT surfaces at 8 and 24 hours when compared to
SLA surfaces. Data are means ± SE. (Single asterisk and double asterisks
denote significant differences between EMD-treated surface and
respective control surfaces, p<0.05 and p<0.01, respectively. Number
sign denotes differences between PT and SLA surfaces (p<0.05). Data
are means ± SE)
Fig. 5 Effects of surface topography and EMD on human gingival
fibroblast cell proliferation for PT control, PT+EMD, SLA control, and
SLA+EMD samples. EMD significantly increased cell numbers on PT
surfaces at 5 days and on SLA surfaces at both 3 and 5 days post-seeding.
Data are means ± SE. (Double asterisks denote significant differences
between EMD-treated surface and respective control surfaces, p<0.01.
Number sign denotes differences between PT and SLA surfaces
(p<0.05). Data are means ± SE)
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The aim of the present study was to investigate the potential
role of EMD on soft tissue healing around titanium implants
with different surface topographies. As such, human primary
gingival fibroblasts were seeded on both PTand SLA surfaces
and analyzed for cell behavior. It was found that cells attached
equally to titanium surfaces irrespective of EMD; however,
EMD had a more prominent influence on cell spreading of
HGFs. It has previously been demonstrated that EMD, which
is typically packaged in an acidic medium with pH ranging
from 4 to 5, will rapidly precipitate to the surface of either
titanium surfaces [44], bone grafting materials [43, 52, 53],
and denuded root surfaces [54] once the pH reaches physio-
logical pH at approximately 7. Once adsorption has taken
place to the surface of the various materials, the amelogenin
aggregates serve as a future protein layer for cell attachment
able to initiate cell spreading [55].
It was also noted in the present study that EMD had a
significant influence on cell proliferation of gingival
fibroblasts seeded on either surface at 5 days. Many numerous
reports have also demonstrated that EMD is able to increase
gingival cell proliferation on cell culture plastic, with one
recent report demonstrating significant increases on zirconia
surfaces [56–61]. It was previously found that EMD induces
proliferation of human gingival fibroblasts via activation of
extracellular regulated kinase (ERK) [61] as well as increased
tyrosine phosphorylation of epidermal growth factor receptor
[60]. Although we have not investigated in detail the cellular
pathways responsible for the significant increases in cell pro-
liferation of gingival fibroblasts cultured on titanium surfaces,
it is likely that the proliferative effects of EMD are via similar
pathways [60–62]. Importantly also, it was found that the
effects were noticed on implant surfaces irrespective of sur-
face topography. There has been a great deal of research per-
formed over the years that has focused on implant surface
topography on both osteoblast and fibroblast cell behavior
[63–66]. Consistent with previous reports from the literature,
Fig. 6 Real-time PCR of genes encoding a collagen 1 (COL1A1), b
fibronectin-1 (FN1), and c vascular endothelial growth factor-A
(VEGFA) for human gingival fibroblasts seeded on PT and SLA
surfaces with and without EMD 5 days post-seeding. It was observed
that EMD was able to significantly upregulate COL1A1, FN1, and
VEGF-A irrespective of surface topography. (Double asterisks denote
significant differences between EMD-treated surface and respective
control surfaces, p<0.01. Number sign denotes differences between PT
and SLA surfaces (p<0.05). Data are means ± SE)
Fig. 7 Immunofluorescence staining of collagen type 1 for human
gingival fibroblasts seeded on PT and SLA surfaces with and without
EMD. It was observed that EMD was able to promote extracellular
matrix deposition and that fluent collagen staining was observed 2
weeks post-seeding on PT + EMD and SLA + EMD surfaces
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it was found in this study that surfaces with rougher topogra-
phies demonstrate reduced cell proliferation and an increase in
extracellular matrix synthesis [62].
We then analyzed the mRNA levels of fibronectin, VEGF,
and collagen 1 via real-time PCR (Fig. 6). It was first noted
that EMD significantly increased the levels of fibronectin
when compared to controls on both PT and SLA surfaces
(Fig. 6b). Fibronectin is a glycoprotein that binds to extracel-
lular matrix components such as collagen, fibrin, and heparin
and aids in cell attachment and future extracellular matrix
synthesis [67, 68]. It was also observed that SLA surfaces
were able to stimulate higher levels of fibronectin mRNA
levels when compared to PT surfaces (Fig. 6b). Previously, it
has been shown that substratum surface topography alters the
cell shape of gingival fibroblasts and modulates fibronectin at
the transcriptional and post-transcriptional levels [64]. Thus, it
may be concluded that not only did surface topography induce
additional expression of FN consistent with the literature [64]
but also EMD seems to further enhance FN mRNA levels on
both PT and SLA surfaces.
We then characterized the effects of surface topography on
gingival cell mRNA expression of VEGF-A, a growth factor
responsible for angiogenesis. It was first found that surface
topography with a roughened surface enabled higher mRNA
levels of VEGF-A (Fig. 6c). Furthermore, EMD markedly
improved VEGF expression on both PT and SLA surfaces,
and this finding was similar to previous reports from the liter-
ature demonstrating the effects of EMD on VEGF production
on tissue culture plastic [69, 70]. Aspriello et al. assessed if
topical EMD application in an instrumented periodontal pock-
et could affect angiogenesis at the gingival level in 56 defects
in 28 humans [69]. After 48 h, gingival biopsies were collect-
ed for histologic and immunohistochemical analysis for
VEGF and CD34 (for microvessel density [MVD] count)
antibodies. It was reported that EMD induces proliferation,
viability, and angiogenesis of human microvascular cells
from human biopsies [69]. Furthermore, Sakado et al.
investigated the effect and the mechanism of action of
EMD on VEGF production by human gingival fibro-
blasts [70]. Their results suggest that EMD stimulates
VEGF production partially via TGF-β1 and fibroblast
growth factor-2 in human gingival fibroblasts and that
EMD-induced VEGF production is regulated by ERK,
p38 MAPK, and PI3K/Akt pathways [70].
Interestingly, in the present study, all mRNA levels were
normalized to control tissue culture plastic. For cells seeded
on PT and SLA surfaces without EMD, it was found that
gingival fibroblasts express higher mRNA levels of collagen
and FN on tissue culture plastic when compared to implant
surfaces of varying topographies. In light of these findings, it
is likely that since tissue culture plastic is already pre-coated
with adhesion molecules known to facilitate fibroblast attach-
ment and growth, HGFs that were seeded on these surfaces are
likely to immediately begin to synthesize molecules such as
FN and COL1A1 quite rapidly. In contrast, implant surfaces
that are completely devoid of any surface proteins may be
retarded due to the fact that cells need to first lay extracellular
matrix protein prior to attachment. Thus, cells seeded on con-
trol PT and SLA may be slightly slowed down in their secre-
tion of COL1A1 and FN synthesis as they must initially pro-
duce their own extracellular matrix proteins for cell attach-
ment (Fig. 6). Interestingly, the addition of EMD improved
expression of both these genes when compared to tissue cul-
ture plastic on both surfaces (Fig. 6). Since EMD contains cell
adhesion molecules such as amelogenin known to influence
cell attachment, it is likely that additional bioactive molecules
found in EMD which are known adhesion molecules are able
to speed up the synthesis of COL1A1 and FN on various
titanium surfaces. This hypothesis however requires further
investigation.
The analysis of collagen 1 immunofluorescence staining
was then performed to investigate the ability for gingival cells
to secrete and synthesize a functional extra cellular matrix. It
was found that EMD upregulared collagen 1 mRNA levels of
gingival fibroblasts seeded on both PT and SLA surfaces
(Fig. 7). More surprisingly was the pattern of ECM deposition
on the various surfaces following exposure to EMD for a 2-
week period. In all four groups, collagen was observed stained
around the cells (Fig. 7). On the surfaces without EMD, how-
ever, there was very little staining interconnected between
cells. The gingival fibroblasts seededwith EMD demonstrated
more dense staining, and the appearance of a continuous ECM
was apparent, especially on PT surfaces where collagen fibrils
seemed to be arranged in a parallel fashion (Fig. 7). One of the
reasons for this observation may be due to the fact that cells on
PT surfaces are more easily able to spread and migrate to one
another, whereas cells seeded on SLA surfaces are more
Fig. 8 Quantification of immunofluorescence staining of collagen type 1
of gingival fibroblasts seeded on PT and SLA surface with and without
EMD at 1 and 2 weeks post-seeding. It was observed that EMD
significantly increased collagen 1 staining on PT surfaces at 1 and 2
weeks and at 2 weeks for SLA surfaces. No significant differences
could be observed between PT and SLA surfaces. Data are means ± SE.
(Single asterisk and double asterisks denote significant difference
between EMD treated surface and respective control surfaces, p<0.05
and p<0.01, respectively)
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confined by their three-dimensional space due to the enhanced
roughened surface.
The enhanced ECM matrix on titanium surfaces cultured
with EMD may play a number of possible roles for enhanced
initial soft tissue attachment to implant surfaces. As the results
from the present study seem to favor soft tissue colonization
onto implant surfaces, it suggests that a faster formation of a
three-dimensional extracellular matrix around the implant sur-
face may also prevent bacterial contamination within the
bone-to-implant region of the titanium surface. It has been
suggested that approximately 50% of implants are lost within
the first year of placement, sometimes even prior to loading,
and one may expect that bacterial contamination may play a
role in this observation. Not only is EMD able to speed up
wound healing/closure, but it has also been reported that EMD
does possess some form of anti-microbial effect which is like-
ly due to the carrier system [71–75]. Furthermore, the use of
EMD significantly increases the expression of VEGF, a
known angiogenic growth factor capable of inducing vascu-
larization. As the soft tissues around implants are much less
vascularized when compared to natural teeth due to the loss of
the periodontal ligament blood supply, it becomes vital that
enough tissue oxygenation be present for the regeneration of
host tissues. As such, the ability for EMD to rapidly increase
angiogenesis is a known advantage that may indirectly be
responsible for its wound healing capabilities. It has also been
reported that a growing concern for peri-implantitis is more
routinely being observed in clinical practice [76]. Froum et al.
has been able to partially regenerate a loss of clinical attach-
ment around implants via a biological approach utilizing a
combination of a membrane, bone graft, and growth factors
including EMD [77]. Future research in this field is necessary
to fully characterize the full potential of EMD on the soft
tissue integration and regeneration of gingival tissues around
titanium implants.
Conclusions
The results from the present study demonstrate the effects of
EMD on gingival fibroblast cell behavior when seeded on PT
and SLA titanium surfaces. Firstly, EMD was able to signifi-
cantly increase cell spreading of cells seeded on PT and SLA
surfaces at various early time points. Furthermore, EMD in-
creased cell proliferation of gingival fibroblasts at 3 and 5 days
on SLA surfaces and 5 days for PTsurfaces when compared to
their respective controls without EMD. Real-time PCR exper-
iments demonstrated that EMD was able to significantly up-
regulate mRNA levels of fibronectin, VEGF-A, and collagen
1. Furthermore, EMD induced ECM synthesis as assessed by
immunofluorescence staining of collagen 1 at 2 weeks post-
seeding. The findings from the present investigation suggest
that EMDmay improve the speed of soft tissue healing around
titanium implant collars. Future animal research is required to
fully characterize the effects of EMD on soft tissue wound
healing around implants.
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